What is the level of liabilities of Sanofi this year?
Sanofi has a debt balance of 52.42 B EUR this year.
Sanofi Liabilities 2024
Sanofi Liabilities
52.42 B EUR
Ticker
SAN.PA
ISIN
FR0000120578
WKN
920657
In 2024, Sanofi's total liabilities amounted to 52.42 B EUR, a 0.94% difference from the 51.94 B EUR total liabilities in the previous year.
Sanofi Aktienanalyse
What does Sanofi do?
Sanofi SA is a French company that was formed in 1973 from a merger of two French pharmaceutical and biotechnology companies. It is one of the largest players in the healthcare industry worldwide and employs over 100,000 employees. The objective of Sanofi is to improve people's lives through innovative medicines and therapies. In this regard, the company pursues a comprehensive business model that focuses on both research and development, as well as the production and distribution of medications and vaccines. The company has different divisions and product lines, which are divided into three business areas: Innovative Medicine, Consumer Healthcare, and Generic Pharmaceuticals. Innovative Medicine utilizes state-of-the-art technologies and scientific knowledge to treat the most challenging diseases. In the area of Consumer Healthcare, the company offers a wide range of over-the-counter products such as vitamins, dietary supplements, cough and cold remedies, as well as oral and dental health products. In the Generic Pharmaceuticals field, the company produces more cost-effective alternatives to expensive brand-name products, providing a variety of generic medications. Sanofi is a leading manufacturer of medications that are of great significance in various areas such as diabetes, oncology, cardiovascular diseases, and neurology. In recent years, the company has also established a strong presence in the field of vaccines. Here, Sanofi develops and produces innovative vaccines against COVID-19, influenza, and other infectious diseases. Sanofi is present in more than 170 countries and collaborates closely with physicians, research institutions, and health authorities to improve healthcare worldwide. The company conducts research and development in various disciplines and invests a significant amount each year in the development of innovative medicines and therapies. Overall, Sanofi SA is an emerging company in the pharmaceutical and healthcare sector. The portfolio of products and therapies offered by Sanofi is extensive and covers many areas of healthcare. Sanofi relies on continuous innovation and continuously works to improve healthcare and enhance the lives of people worldwide. Sanofi ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Sanofi's Liabilities
Sanofi's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Sanofi's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Sanofi's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Sanofi's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Sanofi’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Sanofi stock
What were the liabilities of Sanofi compared to the previous year?
The liabilities of Sanofi have increased by 0.94% increased compared to the previous year.
What are the consequences of high debt for investors of Sanofi?
High liabilities can pose a risk for investors of Sanofi, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Sanofi?
Low liabilities mean that Sanofi has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Sanofi affect the company?
An increase in liabilities of Sanofi can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Sanofi affect the company?
A decrease in the liabilities of Sanofi can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Sanofi?
Some factors that can influence the liabilities of Sanofi include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Sanofi so important for investors?
The liabilities of Sanofi are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Sanofi take to modify the liabilities?
To change its liabilities, Sanofi can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Sanofi pay?
Over the past 12 months, Sanofi paid a dividend of 3.56 EUR . This corresponds to a dividend yield of about 3.61 %. For the coming 12 months, Sanofi is expected to pay a dividend of 3.76 EUR.
What is the dividend yield of Sanofi?
The current dividend yield of Sanofi is 3.61 %.
When does Sanofi pay dividends?
Sanofi pays a quarterly dividend. This is distributed in the months of June, June, June, June.
How secure is the dividend of Sanofi?
Sanofi paid dividends every year for the past 26 years.
What is the dividend of Sanofi?
For the upcoming 12 months, dividends amounting to 3.76 EUR are expected. This corresponds to a dividend yield of 3.8 %.
In which sector is Sanofi located?
Sanofi is assigned to the 'Health' sector.
Wann musste ich die Aktien von Sanofi kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Sanofi from 5/15/2024 amounting to 3.76 EUR, you needed to have the stock in your portfolio before the ex-date on 5/13/2024.
When did Sanofi pay the last dividend?
The last dividend was paid out on 5/15/2024.
What was the dividend of Sanofi in the year 2023?
In the year 2023, Sanofi distributed 3.313 EUR as dividends.
In which currency does Sanofi pay out the dividend?
The dividends of Sanofi are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Sanofi stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von Sanofi
Our stock analysis for Sanofi Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sanofi Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
